Sarepta Therapeutics, Inc. insider trading

SRPTNASDAQ

$17.49-0.01 (-0.06%)as of Oct 5, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 6, 2025 to Oct 5, 2026. Price (-24.8%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26

Unlock quarterly net flow

Key players

RBRichard BarryDirector3.0613%of company
DSDouglas S. IngramChief Executive Officer0.8799%of company
MSMichael SeverinoChief Executive Officer0.7158%of company
MAMichael Andrew ChambersDirector0.4772%of company
MKM. Kathleen BehrensDirector0.2124%of company
LRLouise Rodino-KlapacPresident, R&D and Tech Ops0.193%of company
IMIan Michael EstepanChief Operating Officer0.1677%of company
RHRyan Ho-Yan WongChief Financial Officer0.1153%of company
CRCristin RothfussEVP, General Counsel0.1094%of company
CNClaude NicaiseDirector0.0458%of company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
SRPT	Stephen MayoDirector	Open market sell$123K	-80.4%	$17.02	$123K	Mar 12, 2026	Mar 13, 2026
SRPT	Ian Michael EstepanChief Operating Officer	Open market sell$294K	-6.4%	$22.31	$294K	Dec 16, 2025	Dec 18, 2025

End of history · 2 transactions